Josef Herzog

Prevalence of <i>BRCA</i> Mutations and Founder Effect in High-Risk Hispanic Families

Jeffrey N. Weitzel, Veronica I. Lagos, Kathleen R. Blazer et al. · Cancer Epidemiology Biomarkers & Prevention · 2005 · 172 citations · Full text

Prevalence and Type of<i>BRCA</i>Mutations in Hispanics Undergoing Genetic Cancer Risk Assessment in the Southwestern United States: A Report From the Clinical Cancer Genetics Community Research Network

Jeffrey N. Weitzel, Jessica Clague, Arelis Martir-Negron et al. · Journal of Clinical Oncology · 2012 · 148 citations · Full text

Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

Fergus J. Couch, Karoline Kuchenbaecker, Kyriaki Michailidou et al. · Nature Communications · 2016 · 120 citations · Full text

Evidence for Common Ancestral Origin of a Recurring <i>BRCA1</i> Genomic Rearrangement Identified in High-Risk Hispanic Families

Jeffrey N. Weitzel, Veronica I. Lagos, Josef Herzog et al. · Cancer Epidemiology Biomarkers & Prevention · 2007 · 98 citations

Efficacy of the PARP Inhibitor Veliparib with Carboplatin or as a Single Agent in Patients with Germline <i>BRCA1</i> - or <i>BRCA2</i> -Associated Metastatic Breast Cancer: California Cancer Consortium Trial NCT01149083

George Somlo, Paul Frankel, Banu Arun et al. · Clinical Cancer Research · 2017 · 96 citations · Full text